शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
POLYMEDNSEPoly Medicure Limited· Healthcare Equipment & SuppliesHighNeutral
Announced Thu, 24 Apr, 2025 · 15:16 IST

Poly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.0%Reaction day
₹2422.00
prior close
₹2501.90
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.0%+4.1% vs market
Medical Equipment & Supplies peers, median of 9sector-1.3%+5.4% vs sector

On the reaction day the stock moved 4.1 pts more than Nifty Smallcap 250 and 5.4 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.4
10m
+0.6
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.0-0.0+4.1-1.3+5.4
Next day
+5.4-2.5+7.9-2.1+7.5
2d
+6.7-2.0+8.7-4.1+10.8
3d
+6.4-1.8+8.2-3.7+10.1
4d
+6.5-3.5+10.0-6.0+12.4
5d
+3.7-3.6+7.3-5.3+9.0
1w
+14.6-4.7+19.2-6.7+21.3
15d
-0.1+3.0-3.1+1.2-1.3
1m
+0.4+4.4-4.0+0.4+0.0
2m
-12.7+7.9-20.6+3.9-16.6
3m
-14.5+11.4-25.9+12.4-27.0
UpDownMarket · Nifty Smallcap 250Sector · Medical Equipment & Supplies peers, median of 9Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Poly Medicure Limited has submitted a disclosure to the exchange under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation requires promoters of listed companies to disclose details of their shareholding along with any encumbrances (such as pledges) on those shares. The filing itself is a routine compliance disclosure and no specific details about pledge creation, release, or invocation have been shared in the announcement.

Likely market impact

This is a standard regulatory filing and is unlikely to have any direct material impact on the stock price. Investors should watch for any follow-up details on the nature and extent of encumbrance disclosed.